Telehealth primary care levels off at 6-7% of visits since mid-2023, with highest use in metro areas and adults 25-39, Epic study finds.
After the COVID-19 pandemic, Epic Systems began ramping up efforts in medical research, The Cap Times reported Sept. 18. Before the pandemic, Epic developed its Cosmos database. Caleb Cox, a software ...
The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG ...
The ongoing EPIC clinical trial is the first randomized head-to-head comparison of two neonatal Fc receptor (FcRn)-targeting treatments for generalized myasthenia gravis (gMG) in adults. The phase ...
"The EPIC study marks an important step forward in advancing care for people living with gMG," said Leonard L. Dragone, M.D., Ph.D., Disease Area Leader, Autoantibody and Rheumatology, Johnson & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results